Annual Non Current Assets
$18.86 M
-$4.93 M-20.74%
December 31, 2023
Summary
- As of February 12, 2025, CTMX annual long term assets is $18.86 million, with the most recent change of -$4.93 million (-20.74%) on December 31, 2023.
- During the last 3 years, CTMX annual non current assets has fallen by -$15.79 million (-45.58%).
- CTMX annual non current assets is now -50.31% below its all-time high of $37.95 million, reached on December 31, 2019.
Performance
CTMX Non Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Non Current Assets
$14.80 M
-$1.34 M-8.29%
September 30, 2024
Summary
- As of February 12, 2025, CTMX quarterly long term assets is $14.80 million, with the most recent change of -$1.34 million (-8.29%) on September 30, 2024.
- Over the past year, CTMX quarterly non current assets has dropped by -$5.16 million (-25.86%).
- CTMX quarterly non current assets is now -88.74% below its all-time high of $131.44 million, reached on June 30, 2021.
Performance
CTMX Quarterly Non Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Non Current Assets Formula
Non Current Assets = Property, Plant, and Equipment + Intangible Assets + Long-Term Investments + Deferred Tax Assets + Other Non-Current Assets
CTMX Non Current Assets Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -20.7% | -25.9% |
| 3 y3 years | -45.6% | -25.9% |
| 5 y5 years | +62.1% | -25.9% |
CTMX Non Current Assets Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -35.2% | at low | -49.1% | at low |
| 5 y | 5-year | -50.3% | at low | -88.7% | at low |
| alltime | all time | -50.3% | +283.5% | -88.7% | +138.4% |
CytomX Therapeutics Non Current Assets History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $14.80 M(-8.3%) |
| Jun 2024 | - | $16.14 M(-7.5%) |
| Mar 2024 | - | $17.44 M(-7.5%) |
| Dec 2023 | $182.94 M(-22.8%) | $18.86 M(-5.5%) |
| Sep 2023 | - | $19.96 M(-6.6%) |
| Jun 2023 | - | $21.38 M(-4.3%) |
| Mar 2023 | - | $22.35 M(-6.0%) |
| Dec 2022 | $237.10 M(-23.6%) | $23.79 M(-9.2%) |
| Sep 2022 | - | $26.21 M(-4.0%) |
| Jun 2022 | - | $27.32 M(-3.8%) |
| Mar 2022 | - | $28.38 M(-2.5%) |
| Dec 2021 | $310.30 M(-4.2%) | $29.11 M(-77.6%) |
| Sep 2021 | - | $130.24 M(-0.9%) |
| Jun 2021 | - | $131.44 M(+284.9%) |
| Mar 2021 | - | $34.15 M(-1.4%) |
| Dec 2020 | $324.01 M(+6.8%) | $34.65 M(-0.7%) |
| Sep 2020 | - | $34.88 M(-2.9%) |
| Jun 2020 | - | $35.91 M(-1.9%) |
| Mar 2020 | - | $36.60 M(-3.6%) |
| Dec 2019 | $303.33 M | $37.95 M(+0.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2019 | - | $37.77 M(-2.2%) |
| Jun 2019 | - | $38.61 M(-2.1%) |
| Mar 2019 | - | $39.44 M(+239.0%) |
| Dec 2018 | $445.48 M(+14.6%) | $11.63 M(+13.8%) |
| Sep 2018 | - | $10.22 M(-0.5%) |
| Jun 2018 | - | $10.27 M(+8.9%) |
| Mar 2018 | - | $9.43 M(+4.3%) |
| Dec 2017 | $388.60 M(+106.5%) | $9.04 M(-15.2%) |
| Sep 2017 | - | $10.66 M(-4.6%) |
| Jun 2017 | - | $11.18 M(+1.8%) |
| Mar 2017 | - | $10.97 M(-0.1%) |
| Dec 2016 | $188.15 M(-0.8%) | $10.98 M(+14.8%) |
| Sep 2016 | - | $9.57 M(+31.9%) |
| Jun 2016 | - | $7.25 M(-2.0%) |
| Mar 2016 | - | $7.40 M(-0.8%) |
| Dec 2015 | $189.75 M(+183.8%) | $7.46 M(-23.2%) |
| Sep 2015 | - | $9.71 M(+42.1%) |
| Jun 2015 | - | $6.83 M(+10.0%) |
| Dec 2014 | $66.85 M(+621.5%) | $6.21 M |
| Dec 2013 | $9.27 M | - |
FAQ
- What is CytomX Therapeutics annual long term assets?
- What is the all time high annual non current assets for CytomX Therapeutics?
- What is CytomX Therapeutics annual non current assets year-on-year change?
- What is CytomX Therapeutics quarterly long term assets?
- What is the all time high quarterly non current assets for CytomX Therapeutics?
- What is CytomX Therapeutics quarterly non current assets year-on-year change?
What is CytomX Therapeutics annual long term assets?
The current annual non current assets of CTMX is $18.86 M
What is the all time high annual non current assets for CytomX Therapeutics?
CytomX Therapeutics all-time high annual long term assets is $37.95 M
What is CytomX Therapeutics annual non current assets year-on-year change?
Over the past year, CTMX annual long term assets has changed by -$4.93 M (-20.74%)
What is CytomX Therapeutics quarterly long term assets?
The current quarterly non current assets of CTMX is $14.80 M
What is the all time high quarterly non current assets for CytomX Therapeutics?
CytomX Therapeutics all-time high quarterly long term assets is $131.44 M
What is CytomX Therapeutics quarterly non current assets year-on-year change?
Over the past year, CTMX quarterly long term assets has changed by -$5.16 M (-25.86%)